Pamabrom
Active ingredient
Sold as MIDOL BLOAT RELIEF
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 2
- FDA reports (12 mo)
- 9
Overview
Plain-language summary, compiled from the cited regulatory records
Pamabrom is an active ingredient approved for the relief of temporary water weight gain, bloating, swelling, and a full feeling associated with the premenstrual and menstrual periods [1]. It is a diuretic, which means it helps the body eliminate excess fluid [1].
In the past 12 months, there have been 9 adverse event reports concerning Pamabrom [2]. Some of the top reported adverse reactions include acute kidney injury, increased blood creatinine, increased blood glucose, breast tenderness, and diarrhea [2].
Pamabrom is available in the market and is sold under several brand names [1].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | January 27, 2026 |
| CA Canada | Health Canada | 1 | March 22, 2025 |
USUnited States· FDA
1 product
Uses
Uses For the relief of temporary water weight gain bloating swelling full feeling associated with the premenstrual and menstrual periods.
How to take
CACanada· Health Canada
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
Brands in Canada (1)
Sources & citations
- [1]FDA DailyMed · 186805ed-84fc-e7… · revised January 27, 2026 [PDF]
- [2]Health Canada (DPD) · 02527324 · revised March 22, 2025
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.